Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9286 |
High Similarity |
NPD2801 |
Approved |
0.9161 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9097 |
High Similarity |
NPD1934 |
Approved |
0.8824 |
High Similarity |
NPD1511 |
Approved |
0.8758 |
High Similarity |
NPD5494 |
Approved |
0.872 |
High Similarity |
NPD7473 |
Discontinued |
0.871 |
High Similarity |
NPD1512 |
Approved |
0.8688 |
High Similarity |
NPD3882 |
Suspended |
0.8659 |
High Similarity |
NPD6166 |
Phase 2 |
0.8659 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8659 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.865 |
High Similarity |
NPD6232 |
Discontinued |
0.8563 |
High Similarity |
NPD7074 |
Phase 3 |
0.8562 |
High Similarity |
NPD1465 |
Phase 2 |
0.8562 |
High Similarity |
NPD7819 |
Suspended |
0.8526 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD5844 |
Phase 1 |
0.8503 |
High Similarity |
NPD7054 |
Approved |
0.8457 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8443 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8412 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8405 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8395 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8375 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8364 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8246 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8198 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8194 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8176 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8072 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.807 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8063 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8063 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8039 |
Intermediate Similarity |
NPD943 |
Approved |
0.8036 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8025 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7977 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7949 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7947 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7925 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7923 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7898 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7898 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7898 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7895 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7866 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7848 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7836 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7834 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7833 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7818 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD919 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7643 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD37 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD3748 |
Approved |
0.761 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7593 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7588 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7588 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7572 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7572 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7542 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7542 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7531 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7458 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7425 |
Intermediate Similarity |
NPD920 |
Approved |
0.7425 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7418 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7409 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7378 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7374 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD7698 |
Approved |
0.733 |
Intermediate Similarity |
NPD7697 |
Approved |
0.733 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7322 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7305 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7244 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7238 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7229 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7194 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7194 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7181 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7157 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7135 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7125 |
Intermediate Similarity |
NPD3268 |
Approved |
0.712 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD4749 |
Approved |
0.711 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7091 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7044 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7025 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7019 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.701 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6971 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6963 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6962
|
Remote Similarity |
NPD6696 |
Suspended |